Ventricular Assist Devices Market Trends, Analysis and Epidemiology Forecast by 2032

What are Ventricular Assist Devices?

A mechanical circulatory support device (MCSD) or ventricular assist device (VAD) helps your body pump blood from the ventricles, which are the lower chambers of your heart, to the rest of your body. Surgery can be required to implant a VAD while you wait for a heart transplant or to permanently help your heart beat strongly enough.

Although a Ventricular Assist Device can be implanted in either or both of your heart’s ventricles, the left ventricle is where it is most usually done. It is known as a left ventricular assist device when it is inserted into the left ventricle (LVAD)

The Ventricular Assist Devices Market report from DelveInsight provides an in-depth analysis of Ventricular Assist Devices, as well as historical and forecasted market trends in the 7MM (the US, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Some Key Highlights from the Ventricular Assist Devices Market Report

  • Due to several factors, the market for ventricular assist devices is experiencing an increase in product demand. The prevalence of cardiovascular diseases like heart failure and stroke are on the rise due to several factors, including genetics, aging, obesity, and unhealthy lifestyle choices, as well as the rising number of geriatric patients who are susceptible to chronic diseases worldwide, are expected to support the market.
  • Ventricular Assist Devices market is segmented based on Product Type, By Applications, and End-user.
  • Some of the Ventricular Assist Devices available in the market include Hemodynamic management using CardioMEMS (Abbott Medical Devices), HeartWare® VAS (Medtronic), LVAD implant (Inova Health Care Services), and others.
  • Major players which are active in the Ventricular Assist Devices market include — Abiomed, Inc., Asahi Kasei Corporation (Evaheart Medical U.S.A., Inc.), Abbott Laboratories (St. Jude Medical, Inc.), Berlin Heart GmbH, Jarvik Heart, Inc., Medtronic Plc., Terumo Corporation, Evaheart, Inc., Calon Cardio, SynCardia Systems LLC

Request sample @Ventricular Assist Devices Market Insights

The market report on Ventricular Assist Devices includes an overview of the industry and a PEST Analysis. The report also examines market drivers, market constraints, and unmet medical needs in order to identify the greatest prospects and analyze the market’s underlying potential.

Ventricular Assist Devices Market

Ventricular Assist Devices are categorized as: By Product Type (Left Ventricular Assist Devices, Right Ventricular Assist Devices, And Biventricular Assist Devices), By Application Type (Bridge-To-Transplant [Btt], Destination Therapy, And Others), By Design Type (Transcutaneous Ventricular Assist Devices And Implantable Ventricular Assist Devices), By Type Of Flow (Pulsatile Flow And Continous Flow), By End User (Hospital And Clinics, Ambulatory Surgical Centers, And Others)

The market is broad, with a large variety of products accessible, and key companies such as Abbott Laboratories (St. Jude Medical, Inc.), and Berlin Heart GmbH, among others, are present.

Know more about medical devices @Ventricular Assist Devices Market Outlook

Ventricular Assist Devices Key Companies

  • Abiomed, Inc.
  • Asahi Kasei Corporation (Evaheart Medical U.S.A., Inc.)
  • Abbott Laboratories (St. Jude Medical, Inc.)
  • Berlin Heart GmbH
  • Jarvik Heart, Inc.
  • Medtronic Plc.
  • Terumo Corporation
  • Evaheart, Inc.
  • Calon Cardio
  • SynCardia Systems LLC, and others.

Ventricular Assist Devices Market Drivers

  • Growing number of surgeries
  • Increasing cardiovascular disease population
  • Technological advancements in product development

Ventricular Assist Devices Market Barriers

  • High product pricing
  • Stringent Regulatory Process

Ventricular Assist Devices Unmet Needs

Lengthy product approval process

Get more insights @Ventricular Assist Devices Major Players

Scope for the Report

Coverage: 7MM (the US, EU5 (the UK, Germany, Italy, Spain, and France) and Japan)

Study Period: 2019–27

Ventricular Assist Devices Key Companies: Abiomed, Inc., Asahi Kasei Corporation (Evaheart Medical U.S.A., Inc.), Abbott Laboratories (St. Jude Medical, Inc.), Berlin Heart GmbH, Jarvik Heart, Inc., Medtronic Plc., Terumo Corporation, Evaheart, Inc., Calon Cardio, SynCardia Systems LLC, among others.

Tools Used: PEST Analysis

KOL’s Views

Know more about report offerings @Ventricular Assist Devices Market

Related Reports

Diagnostic Imaging Equipment Market

Diagnostic Imaging Equipment Market By Product (X-Ray Imaging Systems, Computed Tomography (CT) Scanners, Ultrasound Systems, Magnetic Resonance Imaging (MRI) Systems, Nuclear Imaging Systems, Mammography Systems, And Others), By Application (Cardiology, Oncology, Gastroenterology, Gynecology, And Other Applications), By End-User (Hospitals, Diagnostic Imaging Centres, And Others), by geography is expected to grow at a steady CAGR forecast till 2026 owing to rising technological advancement and increasing prevalence of chronic diseases.

Invasive Candidiasis Market

“DelveInsight’s ‘Invasive Candidiasis Market Insight, Competitive Landscape and Market Forecast, 2027’ report delivers an in-depth understanding of Invasive Candidiasis and the historical and forecasted Invasive Candidiasis market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Sialidosis Market

DelveInsight’s “Sialidosis Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Sialidosis, historical and forecasted epidemiology as well as the Sialidosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Filgrastim Biosimilar Insight

DelveInsight’s, “Filgrastim Biosimilar Insight, 2022,” report provides comprehensive insights about 20+ companies and 20+ marketed and pipeline drugs in the Filgrastim Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and non-clinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Ventricular Assist Devices Market

Ventricular Assist Devices Market By Type Of Devices (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps [Intrathecal Infusion Pumps and External Infusion Pumps], Ablation Devices [Radiofrequency Ablation Devices And Cryoablation Devices], And Others), By Application (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, and Others), By Geography is expected to grow at a steady CAGR Forecast till 2027

Latest Reports by DelveInsight

Basal Cell Carcinoma Market | Birch Allergy Market | Bile Duct Neoplasm Market | Gingivitis Market | Lupus Nephritis Market | Severe Hypertriglyceridemia (SHTG) Market | Arthralgia Market | Severe Hypertriglyceridemia (SHTG) Market | Arthralgia Market | Congestive Heart Failure Market | Gingivitis Market | Lupus Nephritis Market | Erythromelalgia Market | AL Amyloidosis Market | Primordial Dwarfism Market | Breast Pumps Market | Hyperuricemia Market | Helicobacter Pylori (H. pylori) Infection Market | AIDS Dementia- Market | Follicular Lymphoma Market | Chronic Pulmonary Hypertension Market | Adrenal Crisis Market | Retinoblastoma Market | Non-Cystic Fibrosis Bronchiectasis Market | Microsatellite Stable Colorectal Cancer Market | Chondrosarcoma Market | Sialidosis Market

For more detailed information visit: https://www.delveinsight.com/eular-conference/eular-2022

To know more about our Competitive Services, Click here: Pharma Competitive Intelligence

https://www.delveinsight.com/consulting/competitive-intelligence-services

--

--

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store